The FDA has approved the investigational new drug application of AS1986NS for prostate cancer detection and treatment.

Danziten, a new formulation of nilotinib, may improve treatment adherence in patients with Philadelphia chromosome-positive ...

After the U.S. Food and Drug Administration recalled thousands of bottles of antidepressants it said contained high levels of a cancer-causing chemical, the federal agency has now upgraded the level ...

Speaker of the House Mike Johnson says releasing the ethics committee report on the Florida lawmaker would set "a terrible ...

Patient dosing has begun in a phase 1 trial evaluating QXL138AM, a masked immunocytokine targeting CD138, in advanced solid ...

Liquidia's collaboration on L606 boosts long-term growth potential. Find out why LQDA stock’s valuation and upcoming launches ...

Q3 2024 Earnings Call Transcript November 14, 2024 Operator: Hello, everyone, and thank you for holding, and welcome to the ...

Good afternoon, ladies and gentlemen, and welcome to the Perimeter Medical Q3 2024 Conference Call. At this time, all lines are in listen-only mode. [Operator Instructions]. This call is being ...

Robert F. Kennedy Jr., best known for public health conspiracy theories and misinformation, doesn't have much of a record on ...

Q3 2024 Earnings Call Transcript November 13, 2024 Operator: Welcome to the Talphera Third Quarter 2024 Financial Results Conference Call. This call is being webcast live via the Events page of the ...

Q3 2024 sales revenue increased 164% year-over-year to $135 thousand.Sequential (quarter-over-quarter) net product revenue growth of 8.3%.Gross profit increased from ($20 thousand) to $24 thousand. WA ...

InflaRx N.V. (Nasdaq: IFRX), a biopharmaceutical company pioneering anti-inflammatory therapeutics targeting the complement system, today announced that the Committee for Medicinal Products for Human ...